Precigen Inc
SWB:I5X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Precigen Inc (I5X) under the Base Case is EUR per share.
Compared with the current market price of 3.96 EUR, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Precigen Does
Precigen is a biotechnology company that builds gene and cell therapies for serious diseases, especially cancer, immune disorders, and infectious diseases. It develops its own therapy platforms and drug candidates rather than selling a physical product line, so its work is centered on research, lab development, and clinical testing. The people who matter most to its business are patients, hospitals, and eventually the doctors who prescribe approved treatments, along with larger drug companies that may partner on development.
- Headquarters
- United States of America US
- Employees
- 160
- IPO date
- Aug 8, 2013
Revenue & Expenses Breakdown
Precigen Inc
Earnings Waterfall
Precigen Inc
Continue I5X Research
Decided on Precigen? Get an email when I5X reaches the price you’d buy at. Free with an account.
Other Precigen listings
What is the Intrinsic Value of one I5X stock?
The intrinsic value for
Precigen Inc (I5X) under the Base Case is EUR.
Is I5X stock undervalued or overvalued?
Compared with the current market price of 3.96 EUR, the stock appears .